Autopsy report · NCT03494010
Hybrid Closed-Loop Insulin Delivery System in Type 1 Diabetes Candidates for a Living Donor Kidney Transplant
Cause of deathSlow enrollment, also staffing, sites or logistics
“PI was unable to enroll anyone.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Yale University
- Sponsor type
- University, hospital or other
- Conditions
- Diabetes, Type 1
- Interventions
- Observation
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- The Effect of Selenium Supplementation Among Pediatric Patients With Burns
“Due to a shift in primary responsibilities, the PI was not longer able to enroll subjects.” - MRI-Guided LITT for Treatment Metastatic Brain Tumors
“PI change and no enrollment ever, therefore no data available.” - Transcranial Stimulation During Sleep to Improve Cognition in Epilepsy
“PI left institution and no subjects enrolled.” - Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever
“Unable to recruit sufficient participants due to lack of funding; PI has left the institution.” - Reconditioning Exercise for COVID-19 Patients Experiencing Residual sYmptoms
“Unable to enroll anyone.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.